Immunization of stromal cell targeting fibroblast activation protein providing immunotherapy to breast cancer mouse model. (Q50883844)

24 March 2018

title

Immunization of stromal cell targeting fibroblast activation protein providing immunotherapy to breast cancer mouse model. (English)

1 reference

24 March 2018

0 references

1 reference

Mingyao Meng

1

1 reference

24 March 2018

Wenju Wang

2

1 reference

24 March 2018

Jun Yan

3

1 reference

24 March 2018

Jing Tan

4

1 reference

24 March 2018

Liwei Liao

5

1 reference

24 March 2018

Jianlin Shi

6

1 reference

24 March 2018

Chuanyu Wei

7

1 reference

24 March 2018

Yanhua Xie

8

1 reference

24 March 2018

Xingfang Jin

9

1 reference

24 March 2018

Li Yang

10

1 reference

24 March 2018

Qing Jin

11

1 reference

24 March 2018

Huirong Zhu

12

1 reference

24 March 2018

Weiwei Tan

13

1 reference

24 March 2018

Fang Yang

14

1 reference

24 March 2018

Zongliu Hou

15

1 reference

24 March 2018

publication date

3 February 2016

1 reference

24 March 2018

published in

Tumor Biology

1 reference

24 March 2018

volume

37

1 reference

24 March 2018

issue

8

1 reference

24 March 2018

page(s)

10317-10327

1 reference

24 March 2018

https://scigraph.springernature.com/pub.10.1007/s13277-016-4825-4

exact match

0 references

cites work

Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

The immunobiology of cancer immunosurveillance and immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Genetic instabilities in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Microenvironmental regulation of cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

T cell exclusion, immune privilege, and the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Immunosuppressive strategies that are mediated by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

21 January 2018

Fibroblasts in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

FAP-α (Fibroblast activation protein-α) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Fibroblasts as efficient antigen-presenting cells in lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Microenvironmental regulation of tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Microenvironmental regulation of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Identification and characterization of a fibroblast marker: FSP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

On cross-priming of MHC class I-specific CTL: rule or exception?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Vascular endothelial growth factor secreted by activated stroma enhances angiogenesis and hormone-independent growth of estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Early role of Fsp1 in epithelial-mesenchymal transformation

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26842926

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Down-regulation of the transporter for antigen presentation, proteasome subunits, and class I major histocompatibility complex in tumor cell lines

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26842926

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-016-4825-4

1 reference

24 March 2018

1 reference

24 March 2018